hVIVO plc (LON:HVO), (formerly Open Orphan plc) a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has announced that it will release its audited final results for the twelve months ended 31 December 2022 on Tuesday 25 April 2023.

Hvivo raises full year sales and earnings guidance
The Dublin-headquartered pharmaceutical services company said it expects to generate full year sales of £55m and earnings margins of 19 per cent Hvivo, the Irish pharmaceutical services company founded by businessman Cathal Friel, has increased its sales and